Exhaled Nitric Oxide and Airway Caliber in Children With Asthma
NCT01645397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2014-01-16
Summary
The purpose of this study is to assess if in steroid naïve asthmatic children with elevated baseline exhaled nitric oxide, treatment with inhaled steroid and normalization of exhaled nitric oxide level results in restoration of the bronchodilator response to deep inhalation.
Conditions
- Asthma in Children
Sponsors & Collaborators
-
Atlantic Health System
lead OTHER
Principal Investigators
-
Dagnachew Assefa, MD · Atlantic Health System
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2013-06-30
- Completion
- 2013-08-31
Countries
- United States
Study Locations
More Related Trials
-
Investigation of Lung Ventilation Inhomogeneity in Pediatric Asthma
NCT01095354 ·Status: COMPLETED
-
Some Biomarkers in Bronchial Asthma in Children
NCT04175093 ·Status: UNKNOWN
-
Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)
NCT00421018 ·Status: COMPLETED ·Phase: NA
-
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
NCT01113853 ·Status: COMPLETED
-
Changes in the Lung Clearance Index in Pediatric Patients With Asthma
NCT02678949 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents
NCT00114413 ·Status: COMPLETED ·Phase: NA
-
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
NCT00809757 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children
NCT03487809 ·Status: RECRUITING
-
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
NCT00522782 ·Status: COMPLETED ·Phase: PHASE4
-
Montelukast With Status Asthmaticus, Ages 6-18
NCT00494572 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma
NCT00500253 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Diagnosis of Asthma in Young Children
NCT00422747 ·Status: COMPLETED ·Phase: NA
-
Exhaled Nitric Oxide and Nasal Lavage Fluid
NCT00773578 ·Status: COMPLETED
-
Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair
NCT00139152 ·Status: COMPLETED ·Phase: PHASE4
-
Albuterol HFA MDI in Pediatric Participants With Asthma
NCT00577655 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Prednisolone Dosing in Children Hospitalized With Asthma
NCT00257933 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-response of Albuterol in Asthmatics
NCT00940927 ·Status: COMPLETED ·Phase: PHASE4
-
Asthma in Children
NCT01286532 ·Status: COMPLETED
-
Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma
NCT05992519 ·Status: COMPLETED
-
The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
NCT02743663 ·Status: COMPLETED
-
Study of Monitoring Exhaled NO in Symptomatic Asthmatic Adults and Children During Anti-inflammatory Treatment
NCT00388570 ·Status: COMPLETED ·Phase: NA
-
Ex Vivo Pilot Study of the Impact of Nasal Breathing During the Administration of Inhaled Corticosteroids by Inhalation Chamber in Asthmatic Children Ages Between 1 and 4-year-old
NCT03364959 ·Status: TERMINATED ·Phase: NA
-
Improvement of FeNO and FEF25-75 After Inhaled Corticosteroid Treatment of Asthma
NCT01340118 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
NCT00569192 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
NCT00641914 ·Status: COMPLETED ·Phase: PHASE4